Calithera Biosciences, Inc. (CALA)
OTCMKTS: CALA · Delayed Price · USD
0.0125
0.00 (0.00%)
Jul 2, 2024, 11:14 AM EDT - Market closed
Calithera Biosciences Market Cap
Calithera Biosciences has a market cap or net worth of $60.91 thousand as of July 3, 2024. Its market cap has decreased by -99.71% in one year.
Market Cap
60.91K
Enterprise Value
-23.72M
1-Year Change
-99.71%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since October 2, 2014, Calithera Biosciences's market cap has decreased from $149.40M to $60.91K, a decrease of -99.96%. That is a compound annual growth rate of -59.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2023 | 1.60M | -89.94% |
| Dec 30, 2022 | 15.90M | -68.07% |
| Dec 31, 2021 | 49.80M | -85.62% |
| Dec 31, 2020 | 346.40M | 12.80% |
| Dec 31, 2019 | 307.10M | 100.85% |
| Dec 31, 2018 | 152.90M | -48.38% |
| Dec 29, 2017 | 296.20M | 339.47% |
| Dec 30, 2016 | 67.40M | -51.48% |
| Dec 31, 2015 | 138.90M | -61.65% |
| Dec 31, 2014 | 362.20M | 142.44% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 861.74B |
| Novo Nordisk | 628.28B |
| UnitedHealth Group | 458.57B |
| Johnson & Johnson | 351.45B |
| Merck & Co. | 323.49B |
| AbbVie | 293.06B |
| AstraZeneca | 238.71B |
| Novartis AG | 208.25B |